Zolgensma, used to treat a rare but often fatal genetic disease, has been approved in Singapore. It is an opportunity to rethink how innovative, expensive gene therapies are financed, say doctors Ng Qin Xiang, Chan Hwei Wuen and Jeremy Lim.Read More
Zolgensma, used to treat a rare but often fatal genetic disease, has been approved in Singapore. It is an opportunity to rethink how innovative, expensive gene therapies are financed, say doctors Ng Qin Xiang, Chan Hwei Wuen and Jeremy Lim.Read More